US2022212021A1PendingUtilityA1

Implantable system for stimulating a human heart or an animal heart

Assignee: BIOTRONIK SE & CO KGPriority: Apr 18, 2019Filed: Mar 29, 2022Published: Jul 7, 2022
Est. expiryApr 18, 2039(~12.7 yrs left)· nominal 20-yr term from priority
A61N 1/3702A61N 1/36521A61N 1/3706A61N 1/395A61N 1/39622A61N 1/3624A61N 1/36564A61N 1/368G16H 50/30
62
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

An implantable system for stimulating a heart contains a processor, a memory, a stimulator, and a first detection unit for detecting a cardiac rhythm disturbance of a cardiac region. The memory includes a computer-readable program, which prompts the processor to carry out the following steps: a) detecting via the first detection unit whether a cardiac rhythm disturbance is present in a cardiac region of a heart of a patient; b) when a cardiac rhythm disturbance is present, selecting a stimulation strategy based on a selection criterion; c) stimulating the cardiac region in which the cardiac rhythm disturbance was detected by way of the stimulator, using the selected stimulation strategy; d) detecting a success and/or an efficiency of the conducted stimulation; e) comparing the success and/or the efficiency to a predefinable success and/or efficiency criterion; and f) if the predefinable success and/or efficiency criterion was not achieved, optimizing the stimulation strategy.

Claims

exact text as granted — not AI-modified
1 . An implantable system for stimulating a heart including a human heart or an animal heart, the implantable system comprising:
 a processor;   a stimulator;   a first detector for detecting a cardiac rhythm disturbance of a cardiac region; and   a memory storing a computer-readable program prompting said processor to carry out the following steps when the computer-readable program is being executed on said processor:
 detecting by way of said first detector whether the cardiac rhythm disturbance is present in the cardiac region of the heart of a patient; 
 selecting a stimulation strategy based on a selection criterion when the cardiac rhythm disturbance is present, the selection criterion including a measurement variable or a variable calculated from the measurement variable, the measurement variable being selected from the group consisting of a physiological measurement variable of the patient, a pathophysiological measurement variable of the patient, and a non-physiological measurement variable indicating a state of the patient; 
 stimulating the cardiac region in which the cardiac rhythm disturbance was detected by way of said stimulator, using a selected stimulation strategy; 
 detecting a success and/or an efficiency of a conducted stimulation; 
 comparing the success and/or the efficiency of the conducted stimulation to a predefinable success and/or efficiency criterion; and 
 optimizing the selected stimulation strategy so as to achieve better success and/or greater efficiency during a subsequent stimulation using an optimized stimulation strategy if the predefinable success and/or efficiency criterion was not achieved, an optimization including a change in the stimulation strategy with respect to at least one parameter, which is selected from the group consisting of a form of a treatment, a number of treatments, a combination of different treatments, a frequency of the treatments, and a point in time of the treatment; 
 wherein the form of the treatment includes a design of a stimulation and/or a pattern of the stimulation; and 
 wherein the stimulation strategy is atrial antitachycardia pacing or cardioversion. 
   
     
     
         2 . The implantable system according to  claim 1 , wherein the measurement variable is or provides a hemodynamic measurement variable of the patient, an amplitude of an intracardiac electrogram, an amplitude of a far field signal, an amplitude of an electrocardiogram signal, an amplitude of an atrial signal, a systemic blood pressure, an arterial blood pressure, a venous blood pressure, a blood pressure in a ventricle, a pulmonary arterial pressure, another blood pressure or a change in one of the aforementioned blood pressures, a change in a morphology of a detected signal, an impedance change of a detected signal, a measurement value allowing a conclusion of a regularity or irregularity of a heart rhythm of the patient, or a body position. 
     
     
         3 . The implantable system according to  claim 1 , wherein the measurement variable is a variable that can be ascertained by the implantable system itself or by way of said first detector or a further detector. 
     
     
         4 . The implantable system according to  claim 1 , wherein the efficiency of the conducted stimulation represents a physiological efficiency and/or an energetic efficiency with respect to energy expended for the conducted stimulation. 
     
     
         5 . The implantable system according to  claim 1 , wherein the computer-readable program prompts said processor to store the selection criterion, an applied stimulation strategy and an achieved success and/or an achieved efficiency in said memory, and to prioritize stored stimulation strategies as a function of the achieved success and/or the achieved efficiency. 
     
     
         6 . The implantable system according to  claim 5 , wherein the computer-readable program prompts said processor to exclude a low-priority stimulation strategy, for a first duration, from the stimulation strategies to be selected for an impending stimulation. 
     
     
         7 . The implantable system according to  claim 1 , wherein the stimulation strategy is atrial antitachycardia pacing or cardioversion. 
     
     
         8 . The implantable system according to  claim 1 , wherein when the detected cardiac rhythm disturbance is atrial tachycardia, the computer-readable program prompts said processor to determine a ventricular cardiac rhythm and to assess the ventricular cardiac rhythm with respect to a risk of retrograde conduction of ventricular tachycardia in at least one of an atria, and to adapt an atrial antitachycardia pacing therapy with respect to a location and/or time of an application as a function of an ascertained risk. 
     
     
         9 . The implantable system according to  claim 1 , wherein said stimulator is configured to carry out the stimulation in a form of electrical stimulation or in a form of optical stimulation. 
     
     
         10 . A method for controlling an operation of an implantable system for stimulating a heart including a human heart or an animal heart, which comprises the following steps of:
 detecting by way of a first detector whether a cardiac rhythm disturbance is present in a cardiac region of the heart of a patient;   selecting a stimulation strategy based on a selection criterion when the cardiac rhythm disturbance is present, the selection criterion including a measurement variable or a variable calculated from the measurement variable, the measurement variable being selected from the group consisting of a physiological measurement variable of the patient, a pathophysiological measurement variable of the patient, and a non-physiological measurement variable indicating a state of the patient, wherein the selected stimulation strategy is atrial antitachycardia pacing or cardioversion;   generating at least one impulse, in a stimulator, for stimulating the cardiac region in which the cardiac rhythm disturbance was detected, using a selected stimulation strategy;   comparing data regarding a success and/or an efficiency of a conducted stimulation to a predefinable success and/or efficiency criterion; and   optimizing the stimulation strategy so as to achieve better success and/or greater efficiency during a subsequent stimulation using an optimized stimulation strategy if the predefinable success and/or efficiency criterion was not achieved, an optimization including a change in the stimulation strategy with respect to at least one parameter, which is selected from the group consisting of a form of a treatment, a number of treatments, a combination of different treatments, a frequency of the treatments, and a point in time of the treatment, wherein the form of the treatment includes a design of a stimulation and/or a pattern of the stimulation.   
     
     
         11 . A computer program product having computer-readable code prompting a processor to carry out the following steps when the computer-readable code is being executed on said processor:
 detecting by way of a first detector whether a cardiac rhythm disturbance is present in a cardiac region of a heart of a patient including a human patient or an animal patient;   selecting a stimulation strategy based on a selection criterion when the cardiac rhythm disturbance is present, the selection criterion including a measurement variable or a variable calculated from the measurement variable, the measurement variable being selected from the group consisting of a physiological measurement variable of the patient, a pathophysiological measurement variable of the patient, and a non-physiological measurement variable indicating a state of the patient, wherein the selected stimulation strategy is atrial antitachycardia pacing or cardioversion;   stimulating the cardiac region in which the cardiac rhythm disturbance was detected by way of a stimulator, using a selected stimulation strategy;   detecting a success and/or an efficiency of a conducted stimulation;   comparing the success and/or the efficiency of the conducted stimulation to a predefinable success and/or efficiency criterion; and   optimizing the stimulation strategy so as to achieve better success and/or greater efficiency during a subsequent stimulation using an optimized stimulation strategy if the predefinable success and/or efficiency criterion was not achieved, an optimization including a change in the stimulation strategy with respect to at least one parameter, which is selected from the group consisting of a form of a treatment, a number of treatments, a combination of different treatments, a frequency of the treatments, and a point in time of the treatment, wherein the form of the treatment includes a design of a stimulation and/or a pattern of the stimulation.   
     
     
         12 . A method for treating a patient including human patient or an animal patient requiring such treatment by way of an implantable system for stimulating a heart of the patient, the implantable system including a processor, a memory, a stimulator, and a first detector for detecting a cardiac rhythm disturbance of a cardiac region, the method comprises the following steps of:
 detecting by way of the first detector whether the cardiac rhythm disturbance is present in the cardiac region of the heart of the patient;   selecting a stimulation strategy based on a selection criterion when the cardiac rhythm disturbance is present, the selection criterion including a measurement variable or a variable calculated from the measurement variable, the measurement variable being selected from the group consisting of a physiological measurement variable of the patient, a pathophysiological measurement variable of the patient, and a non-physiological measurement variable indicating a state of the patient, wherein the selected stimulation strategy is atrial antitachycardia pacing or cardioversion;   stimulating the cardiac region in which the cardiac rhythm disturbance was detected by way of the stimulator, using a selected stimulation strategy;   detecting a success and/or an efficiency of a conducted stimulation;   comparing the success and/or the efficiency of the conducted stimulation to a predefinable success and/or efficiency criterion; and   optimizing the stimulation strategy so as to achieve better success and/or greater efficiency during a subsequent stimulation using an optimized stimulation strategy if the predefinable success and/or efficiency criterion was not achieved, an optimization including a change in the stimulation strategy with respect to at least one parameter, which is selected from the group consisting of a form of a treatment, a number of treatments, a combination of different treatments, a frequency of the treatments, and a point in time of the treatment, wherein the form of the treatment includes a design of a stimulation and/or a pattern of the stimulation.

Join the waitlist — get patent alerts

Track US2022212021A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.